InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (6 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
6
T+90 hit rate
67%
T+90 mean return
+31.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Labrucherie Gil M, Chief Financial Officer. Director active across 5 companies, notably NEKTAR THERAPEUTICS. Aggregated, 19 reports have been logged. Split: 4 buys · 6 sells. Total volume traded: €995k. History available since 17 May 2021. The latest transaction was filed on 19 November 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Labrucherie Gil M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
21,000 shares0Common SharesSEC:0000912282-25-001279:0
9,000 shares0Common SharesSEC:0000912282-25-000664:0
6,282 shares@ US$5.5937.8% of flowCommon StockSEC:0000950170-25-029330:0
Canonical exit: 26 May 2025 (T+90)
10,500 shares@ US$5.50662.2% of flowCommon StockSEC:0000950170-25-025039:0
Canonical exit: 20 May 2025 (T+90)
25,500 shares0Common SharesSEC:0000912282-25-000184:0
40,763 shares0Common StockSEC:0001962918-23-000034:0
28,750 shares0Common StockSEC:0001209191-22-029899:0
52,631 shares@ US$3.800.049% mcap50.0% of flowCommon StockSEC:0001567619-22-009789:0
Canonical exit: 2 Aug 2022 (T+90)
52,631 shares@ US$3.800.049% mcap50.0% of flowCommon StockSEC:0001567619-22-009699:0
Canonical exit: 2 Aug 2022 (T+90)
7,579 shares@ US$10.950.0031% mcap6.9% of flowCommon StockSEC:0001209191-22-011436:0
52,950 shares0Common StockSEC:0001209191-21-070690:0
21,149 shares@ US$13.1646.3% of flowCommon StockSEC:0001209191-21-065592:0
40,150 shares0Common StockSEC:0001209191-21-065220:0
7,867 shares@ US$13.8317.5% of flowCommon StockSEC:0001209191-21-052384:0
7,898 shares@ US$18.3022.5% of flowCommon StockSEC:0001209191-21-034184:0
11,666 sharesCommon StockSEC:0001209191-16-098173:0
11,666 sharesCommon StockSEC:0001209191-16-098173:1
11,667 sharesCommon StockSEC:0001209191-16-092942:0
11,667 sharesCommon StockSEC:0001209191-16-092942:1
19 of 19 declarations
About Labrucherie Gil M
Labrucherie Gil M is Director Financier. He has 19 filings in total, and among the sampled recent filings, the transactions cover the period from 2016-01-21 to 2025-11-21, with buys of EUR 465456 and sells of EUR 529187. The companies mentioned are NEKTAR THERAPEUTICS, Rezolute, Inc., Septerna, Inc. and ACELYRIN, Inc., and the modal transaction nature is Attribution.
